Deva Holding AS Discontinued
FDA Approved Drugs

Deva Holding AS Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 4
  • Latest Approval Date Jan 12, 2024
  • Data Source FDA
  • First Approval Date Jan 12, 2024
All
32
View
Discontinued
4
View
RX
28
View
Company Overview

Company

Deva Holding AS Discontinued

Country

Turkey

Social Profiles

LinkedIn
Company Snapshot

Deva Holding AS Discontinued

Küçükçekmece - İSTANBUL Sicil No: 70061

Turkey

www.deva.com.tr/en/ MAycicek@deva.com.tr View on Map
FDA Approved Drug Records ( 4 records )
2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2024-01-12

210197 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2024-01-12

210197 / 2

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2024-01-12

210197 / 3

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

2024
12 Jan
Discontinued Application: 210197

Drug Name

CEFTRIAXONE

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2024-01-12

210197 / 4

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

210197

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2024-01-12

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    8 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    32 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
4 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CEFTRIAXONE

Application Number

210197

Product Number

1

Active Ingredient

CEFTRIAXONE SODIUM

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.